Does Indiana Medicaid cover GLP-1s for weight loss?

Indiana Medicaid covers Zepbound for sleep apnea and Wegovy for heart risk or MASH, not for weight loss alone

Not for weight loss alone
By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

If you are an adult and weight loss is your only reason, Indiana Medicaid does not cover a GLP-1.

If one of the uses below applies to you, your prescriber can ask Indiana Medicaid to cover that drug. Read the rule and its criteria.

  • Nofor adult weight loss alone
  • Oct 1, 2026when the rules we checked took effect
  • $69/molowest cash price in Indiana, at Embody

Which drugs Indiana Medicaid covers, and for what:

Zepbound
Sleep apnea, preferred
Wegovy
Heart risk, as injection or tablets, or MASH, as the injection

We checked 2 official documents on October 15, 2026. This is information, not medical advice or a benefit decision.

What does a GLP-1 cost without insurance in Indiana?

16 programs that serve Indiana publish a complete monthly price, from $69 at Embody to $299 at Willow.

Programs that serve Indiana, lowest monthly price first

Some programs are affiliate partners, and we may earn a commission if you join through our link. Payment never moves a row. How we rank

8 more programs serve Indiana without one complete monthly price: AgelessRx, Breeze Meds, Collective, Maximus, Nu Image Medical, Oak Longevity, Ro and Sesame Care. Compare their terms in the price index.

We left out 13 programs whose service-area list has a caveat for Indiana or is incomplete, so confirm your address at intake.

A program that serves Indiana still decides whether to prescribe, and it does not take Medicaid. Most sell compounded semaglutide or tirzepatide, which is not FDA-approved. Check a compounded provider before you pay.

  • Lowest in Indiana$69/moAt Embody, the lowest complete monthly price among programs that serve Indiana.
  • National median$149/moThe median advertised recurring price across 11 compounded programs we track, a national benchmark, not a measured Indiana average.
  • National range$69 to $299The lowest and highest advertised recurring prices in that group.

What does Indiana Medicaid cover for GLP-1s?

Here is our summary of the Indiana Medicaid rules we checked, with their criteria and limits.

Indiana Medicaid covers Zepbound only for sleep apnea and Wegovy only for heart risk or MASH, not GLP-1 medicines for weight loss alone, under its statewide preferred drug list effective October 1, 2026, which excludes any agent used to promote weight loss. Indiana applies that list to both fee-for-service and managed-care claims, including the Healthy Indiana Plan. Indiana Medicaid prefers Zepbound but approves it only if you are an adult with moderate to severe obstructive sleep apnea, a BMI of 30 or higher and no diabetes. It lists Wegovy injection as non-preferred and can approve it to lower your heart attack and stroke risk (age 45 or older, BMI 27 or higher, a past heart attack, stroke or artery disease, no diabetes) or for MASH, a liver disease, at fibrosis stage F2 or F3. It limits Wegovy tablets to the heart-risk use, and your prescriber must explain why the injection does not suit you. We did not confirm whether a separate under-21 pathway is still in use, so if you are asking for a child, ask the plan directly.

A drug on the preferred list is not covered for every use, so check the rule for yours. A weight-loss exclusion leaves diabetes and other medical requests to their own rules.

We checked Indiana Medicaid statewide uniform preferred drug list, effective for claims from October 1, 2026 (exclusions page 1, GLP-1 class page 39) on October 15, 2026.

We checked Indiana Medicaid PA criteria: GLP-1 receptor agonists and combinations, July 1, 2026 on October 15, 2026.

What should you ask Indiana Medicaid before you pay?

Call your Medicaid plan, Medicare drug plan or private insurer with these questions, and keep the reference number for each call.

Before you pay cash, confirm:

  • Whether your plan covers your exact drug, form and dose for your diagnosis and age.
  • Whether you are in fee-for-service or a managed-care plan, and who handles your prior authorization.
  • Which records your prescriber must send with the request.
  • Which pharmacy can fill it, and your drug copay apart from any visit, lab or membership fees.
  • Whether paying cash affects your benefits.
  • If the plan says no, the reason in writing, how to ask for a review and the deadline on the notice.

An “insurance accepted” badge does not tell you your benefit, so ask your plan how its review works.

What paperwork does prior authorization need?

Your prescriber sends Indiana Medicaid a request with the records that show you meet the rule for your drug and diagnosis, and Indiana Medicaid decides.

What your prescriber usually sends:

  • The condition the request relies on, as Indiana Medicaid names it: Zepbound for sleep apnea, preferred; Wegovy for heart risk, as injection or tablets, or MASH, as the injection.
  • Your BMI, with the height and weight it comes from and the date your prescriber measured them.
  • Chart notes that document the condition, such as a sleep study for sleep apnea or the liver scarring stage for MASH, where the rule asks for them.
  • The exact drug, form and dose your prescriber requests, and whether you have diabetes, because some routes exclude it.
  • What you have tried already: diet and activity changes, and any earlier medicine the rule asks about.
  • For a renewal, your weight, refill and treatment records since the first approval.

Your prescriber works from these Indiana Medicaid documents:

Your prescriber's office files the request; you cannot file it yourself. If Indiana Medicaid says no, ask for the reason in writing, because the notice tells you how to ask for a review and by when.

How does Medicare cover GLP-1s in Indiana?

Medicare's GLP-1 Bridge follows federal rules in every state, so Indiana Medicaid's policy does not decide your Medicare benefit.

GLP-1 Bridge
If your weight-management prescription qualifies and Humana, CMS's central processor, approves it, your drug copay is $50 a month. That copay does not count toward your Part D out-of-pocket spending.
Regular Part D
Ask your drug plan whether it covers your exact medicine for your diagnosis. A plan denial does not by itself make you eligible for the Bridge. Our Medicare GLP-1 coverage guide goes drug by drug.

We checked CMS's Bridge guidance for Part D plans on September 26, 2026.

Who can help with coverage in Indiana?

Two free official services can help you, and we earn no commission from either.

Medicaid
If a managed-care plan runs your drug benefit, call the member-services number on your card for its criteria and a written decision. Indiana Family and Social Services Administration
Medicare counseling
Your State Health Insurance Assistance Program (SHIP) explains a plan or notice for free. It does not approve a prescription. Indiana SHIP counseling

Questions about GLP-1 access in Indiana

Does Indiana Medicaid cover GLP-1 medication for weight loss?

Indiana Medicaid covers Zepbound only for sleep apnea and Wegovy only for heart risk or MASH, not GLP-1 medicines for weight loss alone, under its statewide preferred drug list effective October 1, 2026, which excludes any agent used to promote weight loss.

Indiana applies that list to both fee-for-service and managed-care claims, including the Healthy Indiana Plan. Indiana Medicaid prefers Zepbound but approves it only if you are an adult with moderate to severe obstructive sleep apnea, a BMI of 30 or higher and no diabetes. It lists Wegovy injection as non-preferred and can approve it to lower your heart attack and stroke risk (age 45 or older, BMI 27 or higher, a past heart attack, stroke or artery disease, no diabetes) or for MASH, a liver disease, at fibrosis stage F2 or F3. It limits Wegovy tablets to the heart-risk use, and your prescriber must explain why the injection does not suit you. We did not confirm whether a separate under-21 pathway is still in use, so if you are asking for a child, ask the plan directly. Before you pay, confirm your exact drug, your diagnosis, any age rules and your plan's authorization steps.

Is Medicare GLP-1 coverage different in Indiana?

Yes.

Medicare's GLP-1 Bridge follows federal eligibility rules in every state, not Indiana Medicaid's policy. Your ordinary Part D coverage depends on your prescription and your drug plan, and the Bridge runs its own eligibility and authorization review.

Can I get GLP-1 medication delivered in Indiana?

Yes, from 24 online programs that publish a service area including Indiana.

At intake, confirm your address, the exact medication and any pharmacy limits, because a state listing does not guarantee you a prescription or a delivery date.

How much does GLP-1 treatment cost in Indiana?

Among programs that serve Indiana, the lowest complete monthly price we found is $69 at Embody.

Across the 11 compounded programs we track nationally, the median advertised recurring price is $149/mo, from $69 to $299. That national figure is not a measured Indiana average, insurance copay or quote for your dose.

Featured Partners

Affiliate partners we feature. We may earn a commission.

Embody

from $69/mo·Compounded

Gala

Current program options·Brand & Compounded

Check the medication, commitment and total price for your selected plan.

Bodybuilding Health+

$179/mo month-to-month·Compounded

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.